Gland Pharma Limited Cash Flow Reinvestment Rate
Gland Pharma Limited cash flow reinvestment rate. Gland Pharma Limited (GLAND) has a Cash Flow Reinvestment Rate of 0.33x as of September 2025, reinvesting Rs1.94 Billion (capex Rs1.94 Billion ) from operating cash flow of Rs5.93 Billion. Explore Gland Pharma Limited cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Gland Pharma Limited (2017–2026)
Cash flow reinvestment rate of Gland Pharma Limited from 2017 to 2026. Historical reinvestment intensity for Gland Pharma Limited across 10 annual periods. Explore reinvestment intensity of Gland Pharma Limited to see what proportion of operating cash flow is directed to capital expenditures.
Gland Pharma Limited Cash Flow Reinvestment Rate by Year (2017–2026)
Gland Pharma Limited cash flow reinvestment rate by year from 2017 to 2026. Year-by-year capital reinvestment analysis for Gland Pharma Limited. For the full cash flow conversion analysis, see how efficiently does Gland Pharma Limited generate cash.
| Year | Reinvestment Rate | Total Reinvested (INR) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2026 | 0.72x | Rs8.90 Billion | Rs12.31 Billion | Rs4.91 Billion | ▼ -68.4% |
| 2025 | 2.28x | Rs20.89 Billion | Rs9.15 Billion | Rs3.85 Billion | ▲ +6.0% |
| 2024 | 2.15x | Rs21.47 Billion | Rs9.97 Billion | Rs3.90 Billion | ▼ -45.2% |
| 2023 | 3.93x | Rs14.31 Billion | Rs3.64 Billion | Rs2.23 Billion | ▲ +174.3% |
| 2022 | 1.43x | Rs11.34 Billion | Rs7.91 Billion | Rs5.22 Billion | ▼ -45.3% |
| 2021 | 2.62x | Rs15.86 Billion | Rs6.05 Billion | Rs2.29 Billion | ▲ +120.6% |
| 2020 | 1.19x | Rs8.33 Billion | Rs7.01 Billion | Rs1.95 Billion | ▼ -37.9% |
| 2019 | 1.91x | Rs3.54 Billion | Rs1.85 Billion | Rs1.36 Billion | ▲ +0.9% |
| 2018 | 1.90x | Rs3.83 Billion | Rs2.02 Billion | Rs851.75 Million | ▲ +118.1% |
| 2017 | 0.87x | Rs4.14 Billion | Rs4.76 Billion | Rs1.16 Billion | — |